Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
K. Ranga R. Krishnan, MD: Informant-Rated Cognitive Symptoms in Normal Aging, Mild Cognitive Impairment, and Dementia
1
x
$
30.00
THE CONTEMPORARY MANAGEMENT OF LUNG CANCER
1
x
$
30.00
The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles
1
x
$
30.00
Switching to Duloxetine Remits Ziprasidone - Edward C. Lauterbach
1
x
$
30.00
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
1
x
$
30.00
Evidence-Based Treatment of Psychiatric Disorders with Comorbid Medical Illnesses: The Need for Large Simple Clinical Trials
1
x
$
30.00
Farmacoterapias: Efectos cardiovasculares y recomendaciones en el uso de psicofarmacos
1
x
$
0.00
Analysis of Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
1
x
$
30.00
View Cart
Checkout
Home
Francisco Valdivia-Muñoz
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain
$
30.00
Add to cart
Details
Page load link
Go to Top
